Autophagy is an evolutionally-conserved machinery involving the degradation and turnover of cytoplasmic material in lysosomes. Autophagy plays a role in cellular homeostasis (1) , antiaging (2, 3, 4) , development (1, 5) , protection of the genome (6) and regulation of cell size (7) . Autophagy may act as a means of defense against bacterium and virus invasion and link to various diseases including cancer (8) (9) (10) , cardiomyopathy (11) and neurodegenerative disorders (12) .
Autophagy starts with the formation of an autophagosome, enclosed within a double membrane that engulfs part of the cytoplasm. During periods of autophagy stimuli, cells respond to either maintain the metabolism essential for survival or execute cell death. Autophagy-essential proteins (Atg) are the molecular basis of autophagy machinery. About thirty Atg proteins in yeast and ten in mammals have been identified. In yeast, the protein kinase target of rapamycin (TOR) mediates autophagy via Atg1-Atg13 kinase complex. Atg1 interacts with multiple components of the autophagic machinery, through direct association, phosphorylation, and/or intracellular localization (13, 14) .
In mammalian systems, autophagosomes fuse with lysosomes to generate autophagolysosomes, which undergo a maturation process by fusing with endocytic compartments and lysosomes (15) . Since it is not known how the Atg1 homolog acts in mammals, a different mechanism may be involved in regulating autophagy.
Beclin 1/Atg6, microtubuleassociated protein 1 light chain 3 (LC3)/Atg8, Atg5, Atg12 and Atg 13 are essential for autophagosome formation in mammalian species (5, (16) (17) (18) (19) (20) . Atg7 and Atg3 are required in the conjugation reaction between Atg12 and Atg5, and in the lipidation of LC3. During the formation of autophagosomes in mammalian cells, LC3 is lipidated via a ubiquitylation-like system (17, 21) , generating a soluble form LC3-I. LC3-I is further modified to a membrane-bound form, LC3-II, which is subsequently localized to autophagosomes and autolysosomes until being degraded by the lysosome.
Beclin 1 was initially isolated as a B-cell lymphoma-2 (Bcl2)-interacting tumor suppressor in mammalian cells (22) . Overexpression of Bcl2 attenuates the formation of the kinase complex Beclin 1-class III PtdIns 3-kinase (PI3KC3) essential for the formation of autophagosomes (23) . The UV radiation resistance-associated gene tumor suppressor (UVRAG) and the activating molecule in Beclin 1-regulated autophagy protein 1 (Ambra1) were identified as new Beclin 1-binding partners that also regulate autophagy by regulating the Beclin 1-PI3KC3 kinase complex. Association of Beclin1 with PI3KC3 is negatively regulated by Bcl2 (22) and positively regulated by UVRAG and Ambra1 (24, 25) . Beclin 1 is homoallelically deleted in many human tumors. Decreased Beclin 1 level causes defective autophagy and breast cancer, but restoration of Beclin 1 induces autophagy and inhibits tumorigenicity of human breast cancer cells (18) . These reports evidence the dependency on Beclin 1 for a functional autophagy mechanism.
Diverse signaling pathways have been reported in the regulation of autophagy in mammalian cells (26, 27) . In contrast to yeast, mammalian cells regulate autophagy via both class I and class III PI3K. Class I PI3K plays an inhibitory role, while class III PI3K kinase complex, which includes Beclin 1, plays a stimulatory role in autophagy by promoting the nucleation of autophagic vesicles (28, 29) . Recent study also indicates that hVps15 is required in regulation of class III PI3K in mammalian cells (30) . However, the signaling mechanisms controlling autophagy-essential proteins, in particular the Beclin 1, and the opposing consequences of autophagy remain to be resolved.
Our present studies identify and position a non-canonical MEK(mitogen activated protein kinase kinase)/ERK(extracellular signalregulated kinase) pathway downstream of AMPK (AMP activated protein kinase) and upstream of TSC (turberous sclerosis complex) and mTOR (mammalian target of rapamycin). This MEK/ERK module regulates autophagy via regulating Beclin1 level through AMPK-MEK/ERK-TSC-mTOR pathway. Moderately enhanced Beclin 1 by transient or moderate activation of MEK/ERK and subsequent inhibition on mTORC1 (mTOR complex 1) or mTORC2 (mTOR complex 2) individually causes protective autophagy. Strongly pronounced Beclin 1 by sustained or strong activation of MEK/ERK followed by dual inhibition on mTORC1 and mTORC2 causes destructive autophagy. Our results thus reveal interesting Beclin 1 thresholds in regulating autophagy.
EXPERIMENTAL PROCEDURES
Reagents-Antibody and reagent sources were the following: LC3, Beclin 1, PI3KC3 (Abgent), Akt, Raptor, Rictor, GβL, β-actin, Raf1, non-phospho or phospho-MEK1/2, ERK1/2, p90RSK, Elk, AMPKα, TSC1, TSC2, mTOR, p90RSK, ElK, 4EBP1 and S6K (Cell Signaling), vitamin D3 (Cayman Chemical), rapamycin and bafilomycin A1 (Calbiochem), pepstatin A (Sigma), PD98059 and AICAR (Toronto Research Chemicals), and compound C (Merck).
Cell culture-Human erythroleukemia K562 cells were grown in IMEM and Rat hepatoma H4IIE cells were grown in DMEM. The cells were starved for amino acid by culturing in Dulbecco's Phosphate Buffered Saline (D-PBS) with 10% of fetal calf serum, or starved for serum by culturing in IMEM (K562) or DMEM (H4IIE).
Mice-C57BL/6 mice were used to test physiological response of the autophagic signaling.
Heart and liver tissues were surgically excised, immediately frozen in liquid nitrogen, ground in liquid nitrogen with a mortar and pestle, and homogenized briefly with an electric blender in 5 M guanidinium thiocyanate, 0.5% sarcosyl, 0.1 M 2-mercaptoethanol, and 25 mM sodium citrate.
DNA constructs and transfectionConstitutively active MEK (218D222D) was ordered from Addgene (31), constitutively active MEK1 mutant with disrupted ERK docking site motif (11A40A99A204A) was created from the MEK1(218D222D) by mutagenesis, wt-ERK1 and dominant negative ERK1 (T202AY204F) was provided by Melanie Cobb (32), constitutive active ERK1 (T217DY221D) was created from the wt-ERK1 by mutagenesis, constitutively active Akt was created as previously described (33) . Rat AMPKα2 kinase-dead construct was made by mutating its cDNA at the lysine residue critical for ATP binding and hydrolysis with lysine 45 changed to arginine, resulting in a cDNA encoding a kinase-dead protein (34) . The mutated cDNA was subcloned into a mammalian expression vector with GFP marker. GFP-LC3 plasmid was from Addgene. The above DNA constructs were transfected into H4IIE cells with DEAE-Dextran or K562 cells with electroporation, followed by selection against G418. Transfectants with a green fluorescent protein (GFP) marker were further sorted by flow cytometry.
RNA interference-RNA interference was performed by transfection of the cells with 20 nanomolars of desalted, purified and annealed double-stranded siRNA against the designated genes using DEAE-Dextran transfection for H4IIE cells or electroporaton for K562 cells. Human siRNA sources: MEK1/2, Raf1, ERK1/2, mTOR, TSC2 (Cell Signaling), Beclin1, p90RSK, Elk, Raptor and Rictor (Santa Cruz).
Kinase assay-mTOR kianse assay was performed as previously described. Radioactivity in GST-4EBP1 was quantitated by Molecular Dynamics PhosphorImager and ImageQuant software (35) .
Autophagy assay-Autophagy was determined by detection of the processing of autophagy marker LC3 by autophagic flux assay (36) , fluorescence microscopic detection of the formation of the autophagosomes in the cells transfected with GFP-LC3 as described (37) .
Immunoblotting and coimmunoprecipitation-Western blotting and coimmunoprecipitation were performed as described (38) 
RESULTS

Autophagy
response is MEK/ERKdependent-To explore the role of MEK/ERK in the induction of autophagy, we examined whether MEK/ERK is activated in response to autophagy stimuli using rat hepatoma H4IIE and human erythroleukemia K562 cells. Autophagic response involves the cleavage of cytosolic LC3-I into a lipidated LC3-II, which is then recruited to the autophagosomal membrane (19, 21 and 39) . Thus, processing of LC3 and punctuate GFP labeled LC3 pattern represents autophagosomes or autophagic responses. Autophagy stimuli including rapamycin or vitamin D3 treatment, amino acid or serum starvation caused autophagic responses shown by the processing of LC3-I into LC3-II. These autophagic activities coincided with MEK/ERK activation in both H4IIE (Fig. 1A ) and K562 cells (Fig. 1B) . To test whether the above coincidence is a causal event, the rat and human cell lines were treated with autophagy stimuli together with MEK inhibitor PD98059. Inhibiting MEK/ERK by PD98059 abolished the autophagic response (Fig. 1A, B (Fig. 1E ), indicating that expressing or maintaining the constitutive Beclin 1 depends on the basal activity of MEK/ERK. However, knockdown of Raf1 by RNA interference or constitutive expression of the Raf1 CR3 domain, the active Raf1, which was proven functional previously (38) , hardly affected the basal activity of MEK/ERK or the constitutive Beclin 1 (Fig. 1E, F) , suggesting that basal MEK/ERK activity conferring the constitutive Beclin 1 may largely be independent of Raf1. We then asked if MEK/ERK activation in response to autophagy stimuli upregulates Beclin 1. Indeed, the increase in Beclin 1 by autophagy stimuli coincided with MEK/ERK activation and inhibiting MEK/ERK activation abolished Beclin 1 upregulation in response to autophagy stimuli in both HII4E and K562 cells (Fig. 1G) . Despite MEK/ERK activation by autophagy stimuli, depleting Beclin 1 by RNA interference abolished autophagic responses (Fig.  1H ). These data thus suggest that both basal Beclin 1 and upregulation of Beclin 1 are MEK/ERK-dependent and MEK/ERK regulates autophagy through regulating Beclin 1 level.
MEK can bypass ERK to trigger autophagy-Previous studies suggested that ERK is required in autophagy; however, the autophagy dependency on ERK was largely concluded from pharmacological inhibition with a MEK inhibitor (43, 44) . To better understand the role of ERK in regulating autophagy, we examined the consequences on autophagy by depleting the ERK1/2 canonical downstream effectors, p90RSK and Elk, by RNA interference in K562 cells. MEK1/2 and ERK1/2 activation triggered by amino acid starvation coincided with the phosphorylation of p90RSK ( Fig. 2A) and Elk (Fig. 2B) . Knockdown of either p90RSK or Elk did not affect the autophagic response to amino acid starvation ( Fig. 2A, B (Fig. 2D) . The above data propose that despite the role of ERK in regulating autophagy to some extent, MEK can bypass ERK to induce autophagy.
AMPK is an upstream regulator of MEK in regulating autophagy-An early study reported that activation of AMPK by addition of the cellpermeable nucleotide analogue AICA riboside (AICAR) in hepatocytes inhibits autophagy (45) . But, a recent study using different mammalian cell types and compound C, a specific AMPK inhibitor, showed that AMPK is required for autophagy (46) . Our results show that starvationcaused MEK activation as well as AMPK activation and autophagic response were inhibited by compound C in H4IIE cells (Fig.  3A) , while inhibition of MEK by PD98059 did not inhibit AMPK activation in response to the starvation (Fig. 3B ), suggesting that AMPK may be an upstream regulator of MEK in modulating autophagy.
To understand how MEK links AMPK, H4IIE cells were treated with AICAR to trigger autophagic responses. Inhibiting MEK did not inhibit AMPK activation by AICAR. AICAR activated MEK and triggered autophagic responses shown by elevated Beclin 1 level and processing of LC3. Inhibiting MEK blocked the autophagic response by AICAR (Fig. 3C ). This result suggests that enhancing Beclin 1 and triggering autophagic responses by AMPK activation depends on MEK activation. Furthermore, co-immunoprecipitation results revealed that MEK interacts with AMPK but not Raf1 in response to autophagy stimuli (Fig. 3D) , and this interaction is apparently caused by activation of AMPK and MEK signaling because activated MEK binds to activated AMPK, but hardly binds to Raf1 upon exposure to autophagy stimuli (Fig. 3E ). In contrast, growth hormone treatment, which is known to activate the canonical Raf/MEK/ERK pathway in H4IIE cells (47) , caused strong Raf1 binding to MEK (Fig. 3D, E) . The results thus propose that MEK interacts with its upstream regulator AMPK, but not Raf1, in response to autophagy stimuli.
To confirm the role of AMPK as an upstream regulator of MEK in regulating autophagy proposed by the pharmacological data, we generated kinase-dead AMPKα2 H4IIE cell line by mutating rat AMPKα2 cDNA at the lysine residue critical for ATP binding and hydrolysis which was reported by an early study (34) . The results show that in kinasedead (KD) AMPKα2 cells, amino acid starvation, which is a strong autophagy stumulus, failed to activate MEK and cause autophagic precessing of LC3 (Fig. 3F) , further supporting the notion that AMPK regulates autophagy via regulating its downstream effector MEK.
MEK/ERK binds to and activates TSC2 in regulating autophagy-AMPK activates TSC2
by phosphorylation (48) while activation of TSC2 suppresses mTOR signaling (49) and activation of AMPK downregulates mTOR activity (50) , supporting a positive role of AMPK in regulating autophagy. Both H4IIE and K562 cells express a dominant TSC2 and a weak TSC1 (Fig. 4A ). To examine whether MEK/ERK plays a role in TSC activation by AMPK, H4IIE cells were stimulated with AICAR, with or without PD98059. Activation of AMPK activated TSC2, but inhibiting MEK inhibited TSC2 activation by AMPK shown by the crippled phosphorylation of TSC2 (Fig. 4B) , suggesting that activation of TSC2 by AMPK is MEK/ERK-dependent.
Upon activation by autophagy stimuli, MEK formed multiple complexes (Fig. 4C ). TSC2 bound to the activated MEK and activated ERK (Fig. 4D ), suggesting that TSC2 is the downstream effector of MEK/ERK in regulation of autophagy.
Physical interaction between TSC2 and ERK was previously reported (51) . TSC2 binds to ERK through the ERK docking site (ERK D domain), consisting of a conserved L/I-X-L/I motif located three to five residues downstream of a cluster of basic amino acids (52) . Since MEK activation can induce autophagy when ERK activation is inhibited (Fig. 2D) , we asked if MEK can directly activate TSC through physical interaction. To test whether MEK interacts with TSC2 through the ERK D domain, the four ERK D domains were disrupted by mutating the four amino acids in the ERK docking site motif (L11A L40A I99A and I204A) of the active MEK1. In the absence of ERK by RNA interference, constitutively active wildtype MEK interacted with TSC2, but disruption of the ERK D domains of MEK1 attenuated this interaction (Fig. 4E) , suggesting that MEK interacted with TSC2 through the ERK D domains.
Constitutively active MEK phosphorylated TSC2 and caused LC3 processing, which was not affected by depleting ERK with RNA interference, but disrupting these docking sites of MEK1 crippled the phosphorylation of TSC2 and the processing of LC3 in the cells that express ERK (Fig. 4F ). These results indicate that MEK binds to and activates TSC2 independent of ERK in regulating autophagy.
AMPK-MEK/ERK-TSC2
signaling functions in physiological response of autophagy-To test if this non-canonical MEK/ERK module physiologically regulates autophagy, we detected MEK/ERK signaling in neonatal mice, which adapt to sudden interruption of trans-placental nutrient by inducing autophagy until supply can be restored through milking (5) . At 5h after birth without milking, the heart and liver samples displayed AMPK and MEK/ERK activation, Beclin 1 upregulation and LC3 processing, as well as MEK/ERK association with AMPK or TSC1 due to nutrient interruption. By contrast, at 120h after birth when the mice began suckling for several days, activation of AMPK or MEK/ERK or physical interaction between MEK/ERK and AMPK or TSC1 was not detected (Fig. 5A, B) . These results suggest that the non-canonical MEK/ERK signaling plays a physiological role in the regulation of mammalian autophagy.
MEK/ERK regulates Beclin 1 through negatively regulating mTORC1 and mTORC2-Unlike positive regulation of autophagy by MEK/ERK, mTOR is a major negative regulator of autophagy. Activation of AMPK and TSC2 upregulates Beclin 1 (Fig. 3C , 4F, 5A) and negatively regulates mTOR activity (48, 49) . Furthermore, AMPK activation of TSC2 depends on MEK/ERK (Fig. 4B) . We thus hypothesize that MEK/ERK may upregulate Beclin 1 and autophagy through downregulation of mTOR. To test this, we made transfectant H4IIE cells constitutively expressing active Akt, which is a known upstream positive regulator of mTOR (53) . Although overexppressing active Akt did not inhibit MEK/ERK activation in response to autophagy stimulus AICAR, it activated mTOR and crippled LC3 processing (Fig. 6A) . Activation of AMPK by AICAR enhanced Beclin 1 level, caused LC3 processing (Fig. 6A ) and the punctuate GFP-LC3 distribution representing autophagy, but active Akt overexpression inhibited them (Fig. 6A, B) . Thus, MEK/ERK activation fails to upregulate Beclin 1 and trigger autophagy when mTOR is activated. These data suggest that MEK/ERK regulates Beclin 1 and autophagy through downregulation of mTOR activity.
The role of MEK/ERK in regulating mTOR activity was further assessed by measuring mTORC1 activity using GST-4EBP1 as substrate. Overexpressing active Akt enhanced mTORC1 activity (Fig. 6C) . Various autophagy stimuli inhibited mTORC1 activity (Fig. 6D) . However, PD98059 released the suppression of mTORC1 activity by MER/ERK activation (Fig.  6D ), indicating that MEK/ERK upregulates autophagy possibly through downregulating mTORC1 activity. Surprisingly, depleting basal MEK/ERK activity by PD98059 almost completely abolished mTORC1 activity (Fig.  6D ). These data suggest that basal MEK/ERK activity is needed for constitutive mTORC1 activity, but pronounced MEK/ERK activation inhibits mTORC1 activity and thus activates autophagy.
Amino acid starvation caused-MEK/ERK activation, ultimately leading to an autophagic response, attenuated the binding of mTOR to Raptor or Rictor, but not GβL (Fig. 6E) , suggesting that assembly of mTOR complexes mTORC1 and mTORC2 is sensitive to MEK/ERK activation, and upregulation of Beclin 1 by MEK/ERK activation, which triggers autophagy, may require inactivation of both mTORC1 and mTORC2. Surprisingly, depleting MEK/ERK activity by PD98059, which depleted basal Beclin1 (Fig. 1E, 3C, 6E ), disassembled both mTORC1 and mTORC2 (Fig.  6E) , suggesting that assembly of mTORC1 and mTORC2 requires basal MEK/ERK activity. It thus appears that basal MEK/ERK activity confers basal mTOR activity by conferring the assembly of complexes mTORC1 and mTORC2 while activation of MEK/ERK inactivates mTOR by disassembling both mTORC1 and mTORC2.
To test whether downregulation of both mTORC1 and mTORC2 is required to upregulate Beclin 1 and trigger autophagy in response to MEK/ERK activation, mTOR, Raptor, or Rictor was knocked down individually or in combination by RNA interference using the K562 cells stably transfected with GFP-LC3. The mTOR is activated in the control cells in rich medium due to basal MEK/ERK activity (Fig. 6D) . The mTOR activity phosphorylated p70S6K and the translation repressor protein, 4EBP1, in control cells (Fig. 6F) . Efficient knockdown of mTOR caused hypophosphorylation of S6K and 4EBP1, enhanced Beclin 1 (Fig. 6F ) and the punctuate distribution of the GFP-LC3 (Fig. 6G) . Knockdown of mTOR plus amino acid starvation caused a more pronounced Beclin 1 and autophagic response. By contrast, Knockdown of Raptor or Rictor individually only caused a moderate enhanced Beclin 1 and weak autophagic responses shown by the LC3 processing determined with autophagic flux, but knockdown of Raptor and Rictor together caused an pronounced Beclin 1and autophagic response, comparable to that caused by global mTOR knockdown (Fig. 6F, G) . These data suggest that efficient upregulation of Beclin 1 attributed to the induction of autophagy requires inactivation of both mTORC1 and mTORC2 activities.
MEK/ERK activation inhibits mTORC1 via TSC2 but inhibits mTORC2 independent of TSC2-TSC2 mediates cellular energy response through regulating mTOR (49) . To determine whether MEK/ERK downregulation of mTOR kinase activity and upregulation of Beclin 1 and autophagy involves TSC1/2, the dominant form of TSC, TSC2, was knocked down by RNA interference using the H4IIE cells transfected with constitutively active MEK or ERK. Constitutive expression of active MEK or active ERK caused dephosphorylation of both 4EBP1 and p70 S6K, the two direct downstream effectors of mTORC1, which coincided with Beclin 1 upregulation and LC3 processing, while knockdown of TSC2 crippled the hypophosphorylation of 4EBP1 and S6K as well as the upregulation of Beclin1 and processing of LC3 (Fig. 7A) . These data suggest that the downregulation of mTORC1 activity by MEK/ERK, upregulation of Beclin 1, and induction of LC3 processing requires TSC2. Knockdown of TSC2 did not cripple activation of MEK/ERK in response to amino acid starvation, but crippled the autophagic response (Fig. 7B) , further confirming that TSC2 is in the downstream of MEK/ERK in the signaling pathway that regulates autophagy.
Autophagy stimuli caused MEK/ERK activation ( Fig. 1) and attenuated mTOR binding to Raptor or Rictor (Fig. 7C) . Knockdown of TSC2 crippled Raptor, but not Rictor, disassociation from mTOR in response to autophagy stimuli that triggers MEK/ERK activation (Fig. 7C) . These data suggest that MEK/ERK inhibition of mTORC1 activity is dependent on TSC2 but MEK/ERK inhibition of mTORC2 is independent of TSC2.
Beclin 1 modulates a protective or destructive autophagy-To explore the signaling mechanisms by which a protective or destructive autophagy is modulated, H4IIE cells were stimulated with amino acid or serum starvation, or treated with rapamycin, in combination with or without autophagy inhibitor bafilomycin A1. Autophagic response increased from 3 to 12 h of amino acid starvation shown by the number of autophagic vacuoles per cell or by the percentage of the cells with GFP-LC3 vacuoles (Fig. 8A, the upper panel) . At 3h, the amino acid starved cells had a decreased cell viability of 88.3% compared to the control cells, which had 97.2% viability. Inhibiting autophagy by bafilomycin A1 further reduced cell viability to 77.5%, suggesting that autophagy played a protective role at 3h of amino acid starvation. At 6h, cell viability dropped to 70.3% in the starved cells, and 69.2% in the starved cells treated with bafilomycin A1, suggesting a balance exists between protective and destructive autophagy. At 12h, cell viability further dropped to 40.3% while treatment with bafilomycin A1 increased the cell viability to 48.3%, suggesting destructive autophagy occurs in the late stage of the starvation (Fig. 8A, the lower panel) . Compared with amino acid starvation, serum starvation caused slower and less intense autophagy (Fig. 8B, the upper panel) . Inhibiting autophagy by bafilomycin A1 reduced cell viability at 24h and did not change the viability at 48h, but increased the viability at 72h compared to the control cells (Fig. 8B , the lower panel), suggesting that autophagy by serum starvation is protective at 24h, neutral at 48h, and destructive at 72h. By contrast, rapamycin caused weak autophagy (Fig. 8C, the upper  panel) . Inhibiting autophagy on the rapamycintreated cells decreased cell viability at 24, 48 and 72h, suggesting that repamycin causes protective autophagy (Fig. 8C, the lower panel) . These data suggest that transient or less intense autophagy stimuli cause protective autophagy, but sustained or intense autophagy stimuli cause destructive autophagy.
Since we observe that MEK/ERK activation triggers autophagy by regulating Beclin 1, we ask whether Beclin 1 regulates both protective and destructive autophagy, and if so, how. The results show that MEK/ERK activation at the three designated time points remained unchanged, but Beclin 1 level was increased along with the starvation, suggesting that lessenhanced Beclin 1 causes protective autophagy, moderately-enhanced Beclin 1 causes neutral autophagy, and strongly-pronounced Beclin 1 causes destructive autophagy (Fig. 8D) . The similar pattern that Beclin 1 level determines autophagic consequences was also revealed by serum starvation, however, serum starvation triggers a slower and less intense autophagy than amino acid starvation (Fig. 8E) . By contrast, rapamycin caused much less enhanced Beclin 1, which was unchanged throughout the protective autophagy response (Fig. 8F) . These data thus suggest that the cellular consequences of autophagy may depend on the longevity of MEK/ERK activation and the enhanced Beclin 1 level.
DISCUSSION
The results presented here demonstrate that a non-canonical MEK/ERK module regulates autophagy by regulating Beclin 1 level through the AMPK-MEK/ERK-TSC-mTOR signaling pathway (Fig.9) We demonstrated in this study that basal MEK/ERK activity maintains the activity of mTORC1 and mTORC2 by protecting them from being disassembled ( Fig. 6E the lower panel), thus maintains basal Beclin1 level incapable of triggering autophagic response (Fig.  1E, 3C , 6E the upper panel). Unexpectedly, we found that although ERK is involved in the regulation of autophagy because constitutive expression of active ERK causes autophagy response (Fig 1C, 7A ) while specific inhibition on ERK by RNA interference (Fig. 2C) or dominant negative ERK (Fig. 2D) partially inhibits autophagy, knockdown of the canonical effectors of ERK, p90RSK and ElK, by RNA interference, did not cripple autophagic response ( Fig. 2A, B) . This unusual observation suggests that ERK may use non-canonical downstream effectors in the context of autophagic signaling. Coincidentally, MEK can bypass ERK (Fig. 2D ) and interact with its downstream effector other than ERK in the context of autophagy stimuli (Fig. 4D , 5B), indicating that ERK is not the sole downstream effector of MEK and MEK plays a more important role than ERK in regulating autophagy.
Interestingly, MEK regulates Golgi fragmentation in mitosis independent of ERK1/2 (58, 59) , and the nucleation of autophagy by Beclin 1-PI3KC3 kinase complex is executed at the trans-Golgi network in mammalian cells (60) , both of which support the unusual role and the non-canonical module of MEK/ERK in regulating Beclin 1 and autophagy.
Recent studies show that ERK upregulates starvation-caused autophagy by downregulating Akt/mTOR/S6K (27) , but the molecular link between this pathway and the basis of autophagy machinery remains largely unclear. We observed here that activation of MEK/ERK coincides with upregulation of Beclin 1 and autophagic responses, and MEK/ERK is activated by AMPK but not Raf1 in response to autophagy stimuli. AMPK has been proposed as a physiological cellular energy sensor because AMP is the most sensitive indicator for a cellular energy status. Cellular ATP concentration is much higher than AMP and an insignificant decrease in ATP levels can result in an extraordinary increase in AMP levels that are sensed by and stimulate AMPK (24) . MEK/ERK activation by AMPK thus confers the sensitivity and accuracy of MEK/ERK in regulating autophagic activity. TSC is known to be regulated by cellular energy levels. Activation of AMPK by energy starvation results in direct phosphorylation of TSC (49) . Our study shows that AMPK activation of TSC depends on ERK/ERK. Furthermore, activated MEK interacted with TSC, and the physical interaction between activated MEK and TSC requires the ERK D docking site sequence motif contained in both MEK and TSC, consistent with the notion that stable binding of substrates to MAPK kinase involves recognition of a docking site on the substrate (2). Furthermore, this noncanonical MEK/ERK signaling pathway functions not only in human and rat cell lines but also in neonatal mice, indicating a physiological significance. Our findings thus position this unusual MEK/ERK module downstream of AMPK and upstream of TSC in response to autophagy stimuli.
Our present study shows that mTOR regulates autophagy caused both by starvation and non-starvation stimuli that activate MEK/ERK, consistent with the report that AMPK regulates autophagy through mTOR also at non-starved conditions (61) , suggesting a possible universal mechanism in the regulation of autophagy through mTOR. Since constitutive expression of Beclin 1 is due to the basal activity of MEK/ERK and enhanced Beclin 1 is attributed to the enhanced MEK/ERK activation in both human and rat cells, we postulate that the dependency of Beclin 1 on MEK/ERK signals may also be a universal mechanism in regulating autophagy. Studies on Beclin 1 demonstrate its increasing importance in the mammalian system, because mammalian species fail to survive in the absence of Beclin 1, develop cancers with low Beclin 1 levels, suppress tumorigenesis with normal Beclin 1 levels, secure a protective autophagy at moderately-enhanced Beclin 1 levels, and suffer from a destructive autophagy when too much Beclin 1 is induced. Thus, our present study adds new understanding of Beclin 1 in the regulation of autophagy.
Beclin 1 plays a central
FIGURE LEGENDS
FIG. 1. Autophagic activity and Beclin1 expression is MEK/ERK-dependent. (A) and (B)
Autophagic response coincides with MEK/ERK signaling. H4IIE and K562 cells were treated with various autophagy stimuli (rapamycin 10μM for 48h, serum depletion for 48h, amino acid depletion for 6h, 50nM vitamin D3 for 72h), with or without 2μM PD98059. 
